Citation:Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB 2013

Citation

Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut 2013 Nov 12 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24221456.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB 2013	What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?	Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHM	completed
Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB 2013 2	Are there groups of patients with non-dysplastic BO that require more frequent surveillance?	Dr Henry To	completed
Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB 2013 3	Are there groups of patients with BO that can be discharged from surveillance?	Conjoint Associate Professor Philip Craig	completed

Compare quality appraisals for each clinical question

• What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma? (compare critical appraisals)
• Are there groups of patients with non-dysplastic BO that require more frequent surveillance? (compare critical appraisals)
• Are there groups of patients with BO that can be discharged from surveillance? (compare critical appraisals)

Cited by

1. Are there groups of patients with BO that can be discharged from surveillance?
2. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
3. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?